ATG9A
(ATG9 Autophagy Related 9 Homolog A (S. Cerevisiae) (ATG9A))
Reactivity
Human, Rat, Mouse
Host
Sheep
Clonality
Polyclonal
Conjugate
This ATG9A antibody is un-conjugated
Application
Western Blotting (WB), Immunohistochemistry (IHC)
Specificity
Specific for ATG9A.
Immunogen
A synthetic peptide from human autophagy-related protein 9A (ATG9A, APG9L1, APG9-like 1) conjugated to an immunogenic carrier protein has been used as the antigen. The antigen is homologous in rat and mouse.
Use at a concentration of 10-50 µg/ml. The optimal workiing concentration should be determined by the end user. Not yet tested in other applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Reconstitute in 500 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice
Avoid freeze and thaw cycles.
Storage
4 °C/-20 °C
Storage Comment
Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date
12 months
Target
ATG9A
(ATG9 Autophagy Related 9 Homolog A (S. Cerevisiae) (ATG9A))
Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly.autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels ofautophagy have been described in some malignant tumors, and a role forautophagy in controlling the unregulated cell growth linked to cancer has been proposed. Subcellular location: Membrane, Multi-pass membrane protein Also known as: ATG9autophagy related 9 homolog A (S. cerevisiae), ATG9A, APG9L1, APG9-like 1, MGD3208.